Global onychomycosis treatment market will reach $5,787.4 million by 2031, growing by 7.9% annually over 2021-2031, driven by the increasing prevalence of chronic medical ailments, the growing geriatric population, improved therapies and preventative solutions, and the rising healthcare expenditure.
Highlighted with 80 tables and 72 figures, this 150-page report “Global Onychomycosis Treatment Market 2021-2031 by Onychomycosis Type (Distal Subungual, White Superficial, Proximal Subungual, Candidal, Others), Treatment Type (Drug Treatment, Laser Therapy, Photodynamic Therapy, Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global onychomycosis treatment market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and the Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify global onychomycosis treatment market in every aspect of the classification from perspectives of Onychomycosis Type, Treatment Type, Distribution Channel, and Region.
Based on Onychomycosis Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Distal Subungual Onychomycosis
• White Superficial Onychomycosis
• Proximal Subungual Onychomycosis
• Candidal Onychomycosis
• Other Onychomycosis Types
Based on Treatment Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Drug Treatment
• Laser Therapy
• Photodynamic Therapy
• Other Therapies
By Distribution Channel, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospitals and Clinics
• Online Stores
• Retail Pharmacies
• Other Distribution Channels
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by Onychomycosis Type, Treatment Type and Distribution Channel over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Bausch Health Companies Inc.
Bayer AG
Cipla Ltd
Dr. Reddys Laboratories Ltd
Galderma SA
GlaxoSmithKline PLC
Johnson & Johnson
Lumenis Ltd
Medimetriks Pharmaceuticals Inc.
Moberg Pharma AB
Novartis AG
Pfizer Inc.
Sanofi SA
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 10
1.2 Research Methodology 13
1.2.1 Overview of Market Research Methodology 13
1.2.2 Market Assumption 14
1.2.3 Secondary Data 14
1.2.4 Primary Data 14
1.2.5 Data Filtration and Model Design 15
1.2.6 Market Size/Share Estimation 16
1.2.7 Research Limitations 17
1.3 Executive Summary 18
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of Global Market by Onychomycosis Type 43
3.1 Market Overview by Onychomycosis Type 43
3.2 Distal Subungual Onychomycosis 45
3.3 White Superficial Onychomycosis 46
3.4 Proximal Subungual Onychomycosis 47
3.5 Candidal Onychomycosis 48
3.6 Other Onychomycosis Types 49
4 Segmentation of Global Market by Treatment Type 50
4.1 Market Overview by Treatment Type 50
4.2 Drug Treatment 52
4.3 Laser Therapy 53
4.4 Photodynamic Therapy 54
4.5 Other Therapies 55
5 Segmentation of Global Market by Distribution Channel 56
5.1 Market Overview by Distribution Channel 56
5.2 Hospitals and Clinics 58
5.3 Online Stores 59
5.4 Retail Pharmacies 60
5.5 Other Distribution Channels 61
6 Segmentation of Global Market by Region 62
6.1 Geographic Market Overview 2021-2031 62
6.2 North America Market 2021-2031 by Country 66
6.2.1 Overview of North America Market 66
6.2.2 U.S. 70
6.2.3 Canada 73
6.2.4 Mexico 75
6.3 European Market 2021-2031 by Country 77
6.3.1 Overview of European Market 77
6.3.2 Germany 81
6.3.3 U.K. 83
6.3.4 France 85
6.3.5 Spain 87
6.3.6 Italy 89
6.3.7 Netherlands 91
6.3.8 Rest of European Market 93
6.4 Asia-Pacific Market 2021-2031 by Country 95
6.4.1 Overview of Asia-Pacific Market 95
6.4.2 Japan 99
6.4.3 China 102
6.4.4 Australia 104
6.4.5 India 106
6.4.6 South Korea 108
6.4.7 Rest of APAC Region 110
6.5 South America Market 2021-2031 by Country 112
6.5.1 Argentina 115
6.5.2 Brazil 117
6.5.3 Chile 119
6.5.4 Rest of South America Market 121
6.6 MEA Market 2021-2031 by Country 122
6.6.1 UAE 125
6.6.2 Saudi Arabia 127
6.6.3 South Africa 129
6.6.4 Other National Markets 131
7 Competitive Landscape 132
7.1 Overview of Key Vendors 132
7.2 New Product Launch, Partnership, Investment, and M&A 135
7.3 Company Profiles 136
Bausch Health Companies Inc. 136
Bayer AG 138
Cipla Ltd 139
Dr. Reddys Laboratories Ltd 140
Galderma SA 141
GlaxoSmithKline PLC 142
Johnson & Johnson 143
Lumenis Ltd 144
Medimetriks Pharmaceuticals Inc. 145
Moberg Pharma AB 146
Novartis AG 147
Pfizer Inc. 148
Sanofi SA 149
RELATED REPORTS 150
List of Tables:
Table 1. Snapshot of Global Onychomycosis Treatment Market in Balanced Perspective, 2021-2031 19
Table 2. World Economic Outlook, 2021-2031 22
Table 3. Clinical Trials of Onychomycosis Treatment 28
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5. Main Product Trends and Market Opportunities in Global Onychomycosis Treatment Market 35
Table 6. Global Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 43
Table 7. Global Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 50
Table 8. Global Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 56
Table 9. Global Onychomycosis Treatment Market by Region, 2021-2031, $ mn 63
Table 10. Leading National Onychomycosis Treatment Market, 2021 and 2031, $ mn 65
Table 11. North America Onychomycosis Treatment Market by Country, 2021-2031, $ mn 68
Table 12. U.S. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 72
Table 13. U.S. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 72
Table 14. U.S. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 72
Table 15. Canada Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 74
Table 16. Canada Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 74
Table 17. Canada Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 74
Table 18. Mexico Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 76
Table 19. Mexico Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 76
Table 20. Mexico Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 76
Table 21. Europe Onychomycosis Treatment Market by Country, 2021-2031, $ mn 80
Table 22. Germany Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 82
Table 23. Germany Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 82
Table 24. Germany Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 82
Table 25. U.K. Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 84
Table 26. U.K. Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 84
Table 27. U.K. Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 84
Table 28. France Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 86
Table 29. France Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 86
Table 30. France Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 86
Table 31. Spain Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 88
Table 32. Spain Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 88
Table 33. Spain Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 88
Table 34. Italy Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 90
Table 35. Italy Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 90
Table 36. Italy Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 90
Table 37. Netherlands Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 92
Table 38. Netherlands Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 92
Table 39. Netherlands Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 92
Table 40. Onychomycosis Treatment Market in Rest of Europe by Country, 2021-2031, $ mn 94
Table 41. APAC Onychomycosis Treatment Market by Country, 2021-2031, $ mn 97
Table 42. Japan Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 101
Table 43. Japan Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 101
Table 44. Japan Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 101
Table 45. China Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 103
Table 46. China Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 103
Table 47. China Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 103
Table 48. Australia Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 105
Table 49. Australia Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 105
Table 50. Australia Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 105
Table 51. India Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 107
Table 52. India Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 107
Table 53. India Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 107
Table 54. South Korea Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 109
Table 55. South Korea Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 109
Table 56. South Korea Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 109
Table 57. Onychomycosis Treatment Market in Rest of APAC by Country/Region, 2021-2031, $ mn 111
Table 58. South America Onychomycosis Treatment Market by Country, 2021-2031, $ mn 114
Table 59. Argentina Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 116
Table 60. Argentina Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 116
Table 61. Argentina Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 116
Table 62. Brazil Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 118
Table 63. Brazil Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 118
Table 64. Brazil Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 118
Table 65. Chile Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 120
Table 66. Chile Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 120
Table 67. Chile Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 120
Table 68. MEA Onychomycosis Treatment Market by Country, 2021-2031, $ mn 124
Table 69. UAE Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 126
Table 70. UAE Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 126
Table 71. UAE Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 126
Table 72. Saudi Arabia Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 128
Table 73. Saudi Arabia Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 128
Table 74. Saudi Arabia Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 128
Table 75. South Africa Onychomycosis Treatment Market by Onychomycosis Type, 2021-2031, $ mn 130
Table 76. South Africa Onychomycosis Treatment Market by Treatment Type, 2021-2031, $ mn 130
Table 77. South Africa Onychomycosis Treatment Market by Distribution Channel, 2021-2031, $ mn 130
Table 78. Bausch Health Companies Inc.: Company Snapshot 136
Table 79. Bausch Health Companies Inc.: Business Segmentation 137
Table 80. Bausch Health Companies Inc.: Product Portfolio 137
